Resultados de Búsqueda por Autor

1

artículo

Draft genome sequences of enterohemorrhagic and enteropathogenic Escherichia coli strains isolated from alpacas in Peru

Publicado por
Maturrano L., Aleman M., Carhuaricra D., Maximiliano J., Siuce J., Luna L., Rosadio R.

Publicado 2018

This study was supported by “Generación Científica-Becas Nacionales-Fortalecimiento de Programas de Doctorado en Universidades Peruanas” grant no. 215-2014-FONDECYT and by the Consejo Nacional de Ciencia y Tecnología (CONCYTEC).

2

artículo

Treating Acute Leukemia During the COVID-19 Pandemic in an Environment With Limited Resources: A Multicenter Experience in Four Latin American Countries

Publicado por
Demichelis-Gómez, R, Alvarado-Ibarra, M, Vasquez-Chávez, J, Delgado-López, N, Gómez-Cortés, C, Espinosa-Bautista, K, Cooke-Tapia, A, Milán-Salvatierra, A, Gómez-De León, A, Lee-Tsai, YL, Rosales-López, D, Cabrera-García, Á, Amador-Medina, F, Córdoba-Ramírez, A, Murrieta-Álvarez, I, Solís-Poblano, JC, Apodaca-Chávez, E, Rangel-Patiño, J, Álvarez-Vera, JL, Arana-Luna, L, De la Peña-Celaya, JA, Espitia-Ríos, ME, Hernández-Ruiz, E, Pérez-Zúñiga, JM, Peña-López, E, González-Rivera, R, García-Leyva, MF, Tejeda-Romero, M, Cruz-Rico, J, Balderas-Delgado, C, Ruíz-Argüelles, GJ, Gómez-Almaguer, D

Publicado 2021

Enlace

Purpose: The COVID-19 pandemic is a colossal challenge for global health; nonetheless, specific subgroups face considerably higher risks for infection and mortality. Among patients with malignant diseases, those with hematologic neoplasms are at a higher risk for poor outcomes. The objective of this study was to register treatment modifications associated with the COVID-19 pandemic and their short-term consequences in Latin America.Methods: Multicenter, prospective, observational, cohort study including patients older than 14 years from 14 centers in four countries (Mexico, Peru, Guatemala, and Panama) who had a confirmed diagnosis of acute leukemia, and who were undergoing active treatment since the first COVID-19 case in each country until the cutoff on July 15, 2020.Results: We recruited 635 patients. Treatment modifications because of the COVID-19 pandemic were reported in 40.8% of c...

3

artículo

Treating Acute Leukemia During the COVID-19 Pandemic in an Environment With Limited Resources: A Multicenter Experience in Four Latin American Countries

Publicado por
Demichelis-Gómez, R, Alvarado-Ibarra, M, Vasquez-Chávez, J, Delgado-López, N, Gómez-Cortés, C, Espinosa-Bautista, K, Cooke-Tapia, A, Milán-Salvatierra, A, Gómez-De León, A, Lee-Tsai, YL, Rosales-López, D, Cabrera-García, Á, Amador-Medina, F, Córdoba-Ramírez, A, Murrieta-Álvarez, I, Solís-Poblano, JC, Apodaca-Chávez, E, Rangel-Patiño, J, Álvarez-Vera, JL, Arana-Luna, L, De la Peña-Celaya, JA, Espitia-Ríos, ME, Hernández-Ruiz, E, Pérez-Zúñiga, JM, Peña-López, E, González-Rivera, R, García-Leyva, MF, Tejeda-Romero, M, Cruz-Rico, J, Balderas-Delgado, C, Ruíz-Argüelles, GJ, Gómez-Almaguer, D

Publicado 2021

Enlace

Purpose: The COVID-19 pandemic is a colossal challenge for global health; nonetheless, specific subgroups face considerably higher risks for infection and mortality. Among patients with malignant diseases, those with hematologic neoplasms are at a higher risk for poor outcomes. The objective of this study was to register treatment modifications associated with the COVID-19 pandemic and their short-term consequences in Latin America. Methods: Multicenter, prospective, observational, cohort study including patients older than 14 years from 14 centers in four countries (Mexico, Peru, Guatemala, and Panama) who had a confirmed diagnosis of acute leukemia, and who were undergoing active treatment since the first COVID-19 case in each country until the cutoff on July 15, 2020. Results: We recruited 635 patients. Treatment modifications because of the COVID-19 pandemic were reported in 40.8% of...